Titel: Towards an Ethics of Responsibility in Human Subject Protection
Termin:
29.11.2006
Veranstaltungsort:
Nongkhai, Thailand
Referenten: Anoja Fernando (FERCAP Steering Committee, Sri Lanka) *** Barbara Sina (Fogarty International Center, US National Institutes of Health) *** Beatrice Loff *** Benjamin Kuo (Joint Institutional Review Board of Taiwan and FERCAP) *** Bernard Schwetz (OHRP) *** Christopher Elias (PATH) *** Cristina E. Torres (FERCAP) *** David Forster (Western Institutional Review Board) *** Dr. Detlef Niese (Novartis) *** Dr. Khanchit *** Dr. Vasantha Muthuswamy (Indian Council for Medical Research and FERCAP) *** Gemiliano Aligue (FERCAP Steering Committee) *** Greg Koski (American Society of Health Reserch Professionals) *** Juntra Karbwang (WHO-TDR) *** Kenji Hirayana (FERCAP Steering Committee) *** Kerry Breen *** Marita Reyes (FERCAP Steering Committee) *** Ock-joo Kim (FERCAP Steering Committee) *** Reijo Salmela (World Health Organization, Western Pacific Region (WPRO)) *** Renato Manaloto (Philosophy Department, University of the Philippines) *** Robert Ridley (WHO TDR) *** Samlee Plianbanchang (World Health Organization, Southeast Asia Regional Office) *** Sang-Goo Shin (College of Medicine, Seoul National University) *** Sirinart Vasanvathana (Food and Drug Administration, Ministry of Public Health, Thailand) *** Suchai Charoenratanakul (Deputy Prime Minister of Thailand) *** Suriadi Gunawan (FERCAP Steering Committee, Indonesia) *** Suwit Wiboolpolprasert (Ministry of Public Health, Thailand) *** Vasantha Musthuswamy *** Vichai Chokevivat (FERCAP & Department for the Development of Thai Traditional and Alternative Medicines, Thailand) *** Zosimo Lee (College of Social Science and Philosophy, University of the Philippines)
Weitere Informationen:
http://www.fercap-sidcer.org/pdf/2006/FERCAP_2006_Updated_Conference_P ...
International guidelines and national laws have been formulated to protect human subjects in research. But the implementation of such documents is dependent on the willingness of various stakeholders to uphold the highest standards of integrity, accountability and transparency in the implementation of health research. The intent to uphold the highest standards of research should also be reinforced through the creation of systems in the various stages of the research process.
This conference will examine the various paradigms to define the roles and
responsibilities of various research stakeholders including national health authorities, sponsors, investigators, editors and their relationship with ethics committees to ensure accountability and transparency in research. Through plenary and parallel sessions, group discussions and country reports, the full range of the system to ensure accountability and transparency is explored.
OBJECTIVES
The primary objective of the Conference is to describe the roles and responsibilities of various research stakeholders to ensure accountability and responsible behaviour in the performance of their tasks in order to develop and improve the ethical framework for research and further ensure the protection of research participants and their communities.
In support of this aim, the conference also has the following specific objectives:
to describe and compare the roles of and responsibilities of various research
stakeholders related to the creation of an ethical infrastructure that supports
accountability and transparency in the Asian and Western Pacific region;
to examine the impact of current international guidelines to make research procedures more transparent;
to identify and share best practices to address problems and barriers in creating accountable and transparent health research systems that protect human subjects and research participants;
to consider best practices in research ethics against a background of
o clear-cut and relevant guidelines and policies related to research ethics;
o value sharing among various research stakeholders;
o synergy among major international, regional and national health decision
makers;
o effective working relationships among important research stakeholders and
Ethics Committees;
to develop a relevant Asian model of an ethical research infrastructure that
encourages accountable and transparent health research policies with national
health policy programs within the context of diverse Asian cultures and religions alongside pluralistic socio-economic and political systems.
CONFERENCE METHODOLOGY
The conference participants are drawn from the various sectors and disciplines
involved in health research. The participants are from Asia and the Western Pacific regions, as well as invited international guests: representatives of national health authorities, ethics committees, researchers and their institutions, and the bio-pharma industry.
CONFERENCE SESSIONS
The conference is composed of plenary sessions for the examination of critical topics and information exchange. These plenary sessions are support by working groups where specific issues explored in-depth and position papers developed.
CONFERENCE OUTCOME
The primary outcome of the conference is the development of a position paper on the potential contribution of Asian and Western Pacific governments to national standards for Good Ethical Review Practice.
Kontakt:
Prof. Cristina E. Torres
FERCAP
Department for the Development of Thai Traditional and Alternative Medicine
Ministry of Public Health
Tiwanond Road
Muang, Nonthaburi 11000
Thailand
Fax: +66 - 2 - 9 51 07 21
torres@fercap-sidcer.org
http://www.fercap-sidcer.org/
Veranstalter: The Forum for Ethical Review Committees in Asia and the Western Pacific Region (FERCAP)
Schlagworte: Ethik-Kommissionen, Genforschung/-technik, Gesundheitswesen